Indivior Pharmaceuticals (INDV) Non Operating Income (2022 - 2024)
Historic Non Operating Income for Indivior Pharmaceuticals (INDV) over the last 3 years, with Q4 2024 value amounting to -$9.0 million.
- Indivior Pharmaceuticals' Non Operating Income fell 100000.0% to -$9.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$19.0 million, marking a year-over-year decrease of 48000.0%. This contributed to the annual value of -$20.0 million for FY2024, which is 50000.0% down from last year.
- According to the latest figures from Q4 2024, Indivior Pharmaceuticals' Non Operating Income is -$9.0 million, which was down 100000.0% from -$5.0 million recorded in Q3 2024.
- In the past 5 years, Indivior Pharmaceuticals' Non Operating Income registered a high of $2.0 million during Q4 2022, and its lowest value of -$9.0 million during Q4 2024.
- In the last 3 years, Indivior Pharmaceuticals' Non Operating Income had a median value of -$2.0 million in 2022 and averaged -$1.7 million.
- In the last 5 years, Indivior Pharmaceuticals' Non Operating Income soared by 20000.0% in 2023 and then plummeted by 100000.0% in 2024.
- Quarter analysis of 3 years shows Indivior Pharmaceuticals' Non Operating Income stood at $2.0 million in 2022, then tumbled by 50.0% to $1.0 million in 2023, then plummeted by 1000.0% to -$9.0 million in 2024.
- Its last three reported values are -$9.0 million in Q4 2024, -$5.0 million for Q3 2024, and -$3.0 million during Q2 2024.